Online Only Articles

Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia

Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
MLL Munich Leukemia Laboratory, Munich, Germany
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Department of Internal Medicine III, Hematology & Oncology, University Hospital of Regensburg, Regensburg
Vol. 100 No. 1 (2015): January, 2015 https://doi.org/10.3324/haematol.2014.115055